Articles On Anteo Diagnostics (ASX:ADO)

AnteoTech Limited (ASX:ADO) has responded sharply on the back of a public announcement informing the market about a $304 million contract bagged by its customer Ellume from the Pentagon for its Emergency Use Authorization (EUA) COVID-19 at...

Nanotech play Anteotech (ASX:ADO) enjoyed a day out today, finishing the day up 8.5c or 85% to finish at 18.5c. ... Read More The post Chart of the Day: US Defense link boosts Anteotech (ASX:ADO) to 85pc rise appeared first on Stockhead.

The AnteoTech Ltd (ASX: ADO) share price has returned from its trading halt and rocketed higher on Wednesday. In afternoon trade, the nanotechnology company’s shares surged a massive 95% higher to a record high of 19.5 cents. Why did the A...

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: ADO) have risen by more than 70 per cent today on the news that customer Ellume bagged a $304 million US Government contract. Ellume, founded by 2020 Brisbane Young Entrepren...

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: ADO) have risen by more than 70 per cent today on the news that customer Ellume bagged a $304 million US Government contract. As announced in October last year, Ellume is a c...

For an unlisted company, Ellume certainly knows how to keep ASX investors talking. The Brisbane-based health company also made news last year. This was due to its announcement that the United States Food and Drug Administration (FDA) had e...

AnteoTech's (ASX: ADO) plans to bring a rapid COVID-19 test to the market have been given a significant shot in the arm through a $1.4 million Queensland Government grant, demonstrating Brisbane's strength as an emerging biotech hub in the...

Summary Queensland Government has awarded funds worth ~A$1.4 million to AnteoTech for its COVID-19 Antigen Rapid Test development. The grant is a strong endorsement of ADO’s development and commercialisation progress. The Company is l...

Summary ASX-listed surface chemistry company AnteoTech is working to facilitate the technology transfer for increasing manufacturing of its COVID-19 test. The Company has commenced the clinical trial of COVID-19 test with VIDRL. Anteo...

24 Dec 2020 - AnteoTech (ASX:ADO) are pushing forward to release their Covid-19 antigen rapid test towards market launch.

ASX large cap biotech Mesoblast (ASX:MSB) is not alone in fighting Acute Respiratory Distress Syndrome (ARDS). ARDS is a disease that hinders the lungs’ ability to operate and is a major culprit of COVID-19 deaths. Essentially it causes lun...

At the time of writing the AnteoTech Ltd [ASX:ADO] share price trades at 10.5 cents, up 5%. AnteoTech announced the company received a cash refund, under the Federal Government’s research and development tax incentive scheme... The post Ant...

27 Nov 2020 - AnteoTech (ASX:ADO) has received a tax refund of almost $1.2 million under the Federal Government’s Research & Development Tax Incentive Scheme.

The AnteoTech Ltd (ASX: ADO) share price is rocketing higher today. This comes after the company announced a design freeze on its COVID-19 Antigen Rapid Test (ART) following successful results. At the time of writing, the Anteotech share p...

AnteoTech (ASX:ADO) says it has received the results of an independent validation study of its COVID-19 Antigen Rapid Test using stored patient swab samples.

The AnteoTech Ltd (ASX: ADO) share price has been a disappointing performer on Wednesday. In afternoon trade the biotech company’s shares are sinking 12% lower to 11 cents. Why is the Anteotech share price sinking lower? Investors have bee...

Buy the dip. Sound investment advice, or a mug’s game? Depending on your approach, it could fall to either side of that line. Timing the market to buy at the lows, or sell at the highs, is educated guess work at best. Which is why you’ll b...

The good news keeps on coming for stocks working on COVID-19 treatments. The latest company to confirm some good news is AnteoTech Ltd [ASX:ADO]. A small-cap biotech firm that has been working on a product that tests for COVID-19 symptoms.....

The Anteotech Ltd (ASX: ADO) share price is up 18.75% in late afternoon trading, after initially leaping by nearly 23% this morning. The surge in the Anteotech share price comes on the heels of the company’s announcement to the ASX just af...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The market...

AnteoTech Ltd’s [ASX:ADO] share price has rocketed up today after it emerged from a trading halt with news it will develop a COVID-19 detection platform. Shares in ADO are up 77.27% or 1.7 cents at the time of writing to trade at 3.9 cents...

A quick wrap of the ASX’s key winners and losers on Thursday, July 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 604 stocks rose, 684 de...

One of the inconveniences of COVID-19 tests is that they can take several hours to complete. A number of ASX stocks are attempting to create faster tests, including two that surged this morning. AnteoTech Ltd (ASX:ADO), which said it has es...

Technologies developed in Brisbane and Melbourne may contribute to a new 15-minute test for COVID-19, harnessing nanocoating to speed up results for saliva and blood tests. Brisbane-based AnteoTech (ASX: ADO) has successfully developed a...

Surface chemistry company AnteoTech (ASX: ADO) emerged from a trading halt this morning to announce a potential breakthrough in the struggle against COVID-19. The company revealed it has developed a proof of concept COVID-19 and flu multipl...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

Queensland-based chemistry company AnteoTech (ASX: ADO) has signed a non-binding heads of agreement with German pharmaceutical and life sciences company Merck to co-develop products for the world’s rapidly-growing point of care diagnostic t...

AnteoTech (ADO) has delivered a solid quarter of development and advanced key business relationships The company’s new cross-linked binder development is progressing quickly and has gathered market interest Feedback will be used for coll...

There are many reasons why a company might change its name, from being taken over to hiding a shady past. This year 114 companies have changed their name. Family cyber security provider Wangle Technologies became the much more fitting Famil...

Small cap stocks comprise of the entities with small market capitalisation. They often provide an edge to individual investors over institutional investors, since they choose to buy large-cap stocks that are deemed as stable ones. However,...

Chemistry and coating company AnteoTech (ASX: ADO) has signed a commercial agreement with IMRA America Inc for the joint development of AnteoBind-coated gold particles to be used in point-of-care diagnostics. Under the agreement, AnteoTech...

Diversification Investing across multiple asset classes, sectors and geographies help an investor to manage their risks effectively. It supports in narrowing down an array of results between anticipated and the best return from an investmen...

Last week appeared to be a good time to buy, judging by the number of trades above $100,000; but two directors not only couldn’t buy, but had to sell. Why? The Taxman. Kogan’s (ASX:KGN) Harry Debney sold nearly $1m of stock to pay a tax bi...

Anteo Diagnostics (ASX:ADO) has announced the appointment of Derek Thomson as its new chief executive officer.

Anteo Diagnostics: Recharging the batteries By Pitt Street Research A potential Lithium-Ion Battery Revolutionary Anteo Diagnostics ((ADO)), having developed what is arguably the world’s most versatile surface modification technology, spent...

Health and medical industry of Australia focuses on the world’s leading technology, advanced research, development and innovation. Over the years, the industry has registered strong growth in terms of both size and reputation. Let us discus...

Anteo Diagnostics’s (ASX:ADO) nano-coating tech has caught the attention of another major player in the global lithium-ion supply chain. The Anteo silicon-based tech could support the production of lithium-ion batteries with up to 75 per ce...

Penny stocks are those stocks that trade at a meagre price usually less than A$1.00, and the company has a very low market capitalization, below A$300 million. These kinds of stocks are characterised by high volatility and thus are consider...

Anteo Diagnostics (ASX:ADO) has signed a collaboration agreement with California based Point-of-Care (POC) company Lumos Diagnostics.